Key result
The rationale for using vasodilators in aortic regurgitation is based on the excess afterload and left ventricular pressure overload associated with the condition.
Why the study?
Do vasodilators improve outcomes in patients with aortic regurgitation?
Do vasodilators improve outcomes in patients with aortic regurgitation?
Answers are grounded in this paper and cite their sources.
Discusses the theoretical basis and clinical evidence for using vasodilators to reduce afterload in patients with aortic regurgitation.
Although aortic regurgitation imposes a volume load on the left ventricle, it became clear more than two decades ago that the resulting large stroke volume and wide pulse pressure also lead to systolic hypertension and concomitant left ventricular pressure overload.1,2 In fact, afterload is much higher in aortic regurgitation than in mitral regurgitation and may be as high as that in the more typically recognized pressure overload of aortic stenosis.3 The excess afterload in aortic regurgitation, in turn, forms the basis for the idea that afterload-reducing agents, such as vasodilators, might be beneficial in the medical treatment of this . . .
No takes yet. Share an insight, caveat, or question.
Blasé A. Carabello (2005) conducted an editorial in Aortic Regurgitation. Vasodilators was evaluated. The rationale for using vasodilators in aortic regurgitation is based on the excess afterload and left ventricular pressure overload associated with the condition.
Synapse has enriched 10 related papers. Consider them for comparative context: